Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Quantitative proteomic analysis of a genetically induced prostate inflammation mouse model via custom 4-plex DiLeu isobaric labeling.

Hao L, Thomas S, Greer T, Vezina CM, Bajpai S, Ashok A, De Marzo AM, Bieberich CJ, Li L, Ricke WA.

Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1236-F1243. doi: 10.1152/ajprenal.00387.2018. Epub 2019 Apr 17.

PMID:
30995113
2.

Consequences of interleukin 1β-triggered chronic inflammation in the mouse prostate gland: Altered architecture associated with prolonged CD4+ infiltration mimics human proliferative inflammatory atrophy.

Ashok A, Keener R, Rubenstein M, Stookey S, Bajpai S, Hicks J, Alme AK, Drake CG, Zheng Q, Trabzonlu L, Yegnasubramanian S, De Marzo AM, Bieberich CJ.

Prostate. 2019 May;79(7):732-745. doi: 10.1002/pros.23784. Epub 2019 Mar 22.

PMID:
30900284
3.

Comprehensive urinary metabolomic characterization of a genetically induced mouse model of prostatic inflammation.

Hao L, Shi Y, Thomas S, Vezina CM, Bajpai S, Ashok A, Bieberich CJ, Ricke WA, Li L.

Int J Mass Spectrom. 2018 Nov;434:185-192. doi: 10.1016/j.ijms.2018.09.017. Epub 2018 Sep 22.

4.

If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease.

Sfanos KS, Yegnasubramanian S, Nelson WG, Lotan TL, Kulac I, Hicks JL, Zheng Q, Bieberich CJ, Haffner MC, De Marzo AM.

Asian J Urol. 2019 Jan;6(1):10-25. doi: 10.1016/j.ajur.2018.11.006. Epub 2018 Dec 12. Review.

5.

Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy.

Xu X, Wu J, Liu S, Saw PE, Tao W, Li Y, Krygsman L, Yegnasubramanian S, De Marzo AM, Shi J, Bieberich CJ, Farokhzad OC.

Small. 2018 Oct;14(41):e1802565. doi: 10.1002/smll.201802565. Epub 2018 Sep 17.

PMID:
30230235
6.

Characterization of novel cell lines derived from a MYC-driven murine model of lethal metastatic adenocarcinoma of the prostate.

Markowski MC, Hubbard GK, Hicks JL, Zheng Q, King A, Esopi D, Rege A, Yegnasubramanian S, Bieberich CJ, De Marzo AM.

Prostate. 2018 Sep;78(13):992-1000. doi: 10.1002/pros.23657. Epub 2018 May 30.

PMID:
29851094
7.

Think 500, not 50! A scalable approach to student success in STEM.

LaCourse WR, Sutphin KL, Ott LE, Maton KI, McDermott P, Bieberich C, Farabaugh P, Rous P.

BMC Proc. 2017 Dec 4;11(Suppl 12):24. doi: 10.1186/s12919-017-0094-5. eCollection 2017.

8.

Erratum: ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development.

Sreenath TL, Macalindong SS, Mikhalkevich N, Sharad S, Mohamed A, Young D, Borbiev T, Xavier C, Gupta R, Jamal M, Babcock K, Tan SH, Nevalainen MT, Dobi A, Petrovics G, Sesterhenn IA, Rosner IL, Bieberich CJ, Nelson P, Vasioukhin V, Srivastava S.

Sci Rep. 2017 Sep 6;7(1):10693. doi: 10.1038/s41598-017-09612-4.

9.

ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development.

Sreenath TL, Macalindong SS, Mikhalkevich N, Sharad S, Mohamed A, Young D, Borbiev T, Xavier C, Gupta R, Jamal M, Babcock K, Tan SH, Nevalainen MT, Dobi A, Petrovics G, Sesterhenn IA, Rosner IL, Bieberich CJ, Nelson P, Vasioukhin V, Srivastava S.

Sci Rep. 2017 Apr 24;7(1):1109. doi: 10.1038/s41598-017-01187-4. Erratum in: Sci Rep. 2017 Sep 6;7(1):10693.

10.

Quantifying Kinase-Specific Phosphorylation Stoichiometry Using Stable Isotope Labeling In a Reverse In-Gel Kinase Assay.

Li X, Cox JT, Huang W, Kane M, Tang K, Bieberich CJ.

Anal Chem. 2016 Dec 6;88(23):11468-11475. Epub 2016 Nov 18.

11.

Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants.

Padmanabhan A, Rao V, De Marzo AM, Bieberich CJ.

Prostate. 2016 May;76(6):523-33. doi: 10.1002/pros.23144. Epub 2016 Feb 4. Review.

PMID:
26841725
12.

Identification of infusion strategy for achieving repeatable nanoparticle distribution and quantification of thermal dosage using micro-CT Hounsfield unit in magnetic nanoparticle hyperthermia.

LeBrun A, Joglekar T, Bieberich C, Ma R, Zhu L.

Int J Hyperthermia. 2016;32(2):132-43. doi: 10.3109/02656736.2015.1119316. Epub 2016 Jan 12.

PMID:
26758242
13.

Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.

Hubbard GK, Mutton LN, Khalili M, McMullin RP, Hicks JL, Bianchi-Frias D, Horn LA, Kulac I, Moubarek MS, Nelson PS, Yegnasubramanian S, De Marzo AM, Bieberich CJ.

Cancer Res. 2016 Jan 15;76(2):283-92. doi: 10.1158/0008-5472.CAN-14-3280. Epub 2015 Nov 10.

14.

Functional and molecular features of the Id4+ germline stem cell population in mouse testes.

Chan F, Oatley MJ, Kaucher AV, Yang QE, Bieberich CJ, Shashikant CS, Oatley JM.

Genes Dev. 2014 Jun 15;28(12):1351-62. doi: 10.1101/gad.240465.114. Erratum in: Genes Dev. 2014 Aug 1;28(15):1733.

15.

A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Peltonen K, Colis L, Liu H, Trivedi R, Moubarek MS, Moore HM, Bai B, Rudek MA, Bieberich CJ, Laiho M.

Cancer Cell. 2014 Jan 13;25(1):77-90. doi: 10.1016/j.ccr.2013.12.009.

16.

Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner.

Padmanabhan A, Li X, Bieberich CJ.

J Biol Chem. 2013 May 17;288(20):14158-69. doi: 10.1074/jbc.M112.432377. Epub 2013 Mar 15.

17.

Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.

Padmanabhan A, Gosc EB, Bieberich CJ.

J Cell Biochem. 2013 May;114(5):1050-7. doi: 10.1002/jcb.24444.

PMID:
23129228
18.

Phosphorylation of NuMA by Aurora-A kinase in PC-3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization.

Toughiri R, Li X, Du Q, Bieberich CJ.

J Cell Biochem. 2013 Apr;114(4):823-30. doi: 10.1002/jcb.24421.

PMID:
23097092
19.

Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.

Rao V, Guan B, Mutton LN, Bieberich CJ.

J Biol Chem. 2012 Oct 19;287(43):36331-40. doi: 10.1074/jbc.M112.352823. Epub 2012 Aug 21.

20.

Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.

Li X, Rao V, Jin J, Guan B, Anderes KL, Bieberich CJ.

J Proteome Res. 2012 Jul 6;11(7):3637-49. doi: 10.1021/pr3000514. Epub 2012 Jun 18.

21.

A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate.

Rao V, Heard JC, Ghaffari H, Wali A, Mutton LN, Bieberich CJ.

Prostate. 2012 Jul 1;72(10):1045-51. doi: 10.1002/pros.22490. Epub 2012 Feb 1.

22.

MYC and Prostate Cancer.

Koh CM, Bieberich CJ, Dang CV, Nelson WG, Yegnasubramanian S, De Marzo AM.

Genes Cancer. 2010 Jun;1(6):617-28. doi: 10.1177/1947601910379132.

23.

ERG gene rearrangements are common in prostatic small cell carcinomas.

Lotan TL, Gupta NS, Wang W, Toubaji A, Haffner MC, Chaux A, Hicks JL, Meeker AK, Bieberich CJ, De Marzo AM, Epstein JI, Netto GJ.

Mod Pathol. 2011 Jun;24(6):820-8. doi: 10.1038/modpathol.2011.7. Epub 2011 Feb 18.

24.

Prostate cancer: New answers prompt new questions regarding cell of origin.

De Marzo AM, Nelson WG, Bieberich CJ, Yegnasubramanian S.

Nat Rev Urol. 2010 Dec;7(12):650-2. doi: 10.1038/nrurol.2010.188.

25.

Ets family protein, erg expression in developing and adult mouse tissues by a highly specific monoclonal antibody.

Mohamed AA, Tan SH, Mikhalkevich N, Ponniah S, Vasioukhin V, Bieberich CJ, Sesterhenn IA, Dobi A, Srivastava S, Sreenath TL.

J Cancer. 2010 Oct 25;1:197-208.

26.

NKX3.1 as a marker of prostatic origin in metastatic tumors.

Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, Eberhart CG, Clark DP, Bieberich CJ, Epstein JI, De Marzo AM.

Am J Surg Pathol. 2010 Aug;34(8):1097-105. doi: 10.1097/PAS.0b013e3181e6cbf3.

27.

Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.

Khalili M, Mutton LN, Gurel B, Hicks JL, De Marzo AM, Bieberich CJ.

Am J Pathol. 2010 May;176(5):2259-68. doi: 10.2353/ajpath.2010.080747. Epub 2010 Apr 2.

28.

MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.

Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL, Bethel C, Lotz MT, Yegnasubramanian S, Nelson WG, Dang CV, Xu M, Anele U, Koh CM, Bieberich CJ, De Marzo AM.

PLoS One. 2010 Feb 25;5(2):e9427. doi: 10.1371/journal.pone.0009427.

29.

A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland.

McMullin RP, Dobi A, Mutton LN, Orosz A, Maheshwari S, Shashikant CS, Bieberich CJ.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):98-103. doi: 10.1073/pnas.0902001107. Epub 2009 Dec 14.

30.

Hoxb13 regulatory elements mediate transgene expression during prostate organogenesis and carcinogenesis.

McMullin RP, Mutton LN, Bieberich CJ.

Dev Dyn. 2009 Mar;238(3):664-72. doi: 10.1002/dvdy.21870.

31.

Serial displacement chromatofocusing and its applications in multidimensional chromatography and gel electrophoresis: II. Experimental results.

Shen H, Li X, Bieberich C, Frey DD.

J Chromatogr A. 2009 Feb 6;1216(6):977-84. doi: 10.1016/j.chroma.2008.12.003. Epub 2008 Dec 7.

PMID:
19128804
32.

Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.

Hansel DE, Nakayama M, Luo J, Abukhdeir AM, Park BH, Bieberich CJ, Hicks JL, Eisenberger M, Nelson WG, Mostwin JL, De Marzo AM.

Prostate. 2009 May 1;69(6):603-9. doi: 10.1002/pros.20910.

33.

Reducing sample complexity in proteomics by chromatofocusing with simple buffer mixtures.

Shen H, Li X, Bieberich CJ, Frey DD.

Methods Mol Biol. 2008;424:187-203. doi: 10.1007/978-1-60327-064-9_16. Review.

PMID:
18369863
34.

Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.

Guan B, Pungaliya P, Li X, Uquillas C, Mutton LN, Rubin EH, Bieberich CJ.

J Biol Chem. 2008 Feb 22;283(8):4834-40. Epub 2007 Dec 12.

35.

The reverse in-gel kinase assay to profile physiological kinase substrates.

Li X, Guan B, Srivastava MK, Padmanabhan A, Hampton BS, Bieberich CJ.

Nat Methods. 2007 Nov;4(11):957-62. Epub 2007 Oct 21.

PMID:
17952089
36.

Loss of Nkx3.1 expression in the transgenic adenocarcinoma of mouse prostate model.

Bethel CR, Bieberich CJ.

Prostate. 2007 Dec 1;67(16):1740-50.

PMID:
17929276
37.

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.

Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.

Am J Surg Pathol. 2007 Aug;31(8):1246-55.

PMID:
17667550
38.

Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.

Bethel CR, Faith D, Li X, Guan B, Hicks JL, Lan F, Jenkins RB, Bieberich CJ, De Marzo AM.

Cancer Res. 2006 Nov 15;66(22):10683-90.

39.

Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouse.

Dai B, Kim O, Xie Y, Guo Z, Xu K, Wang B, Kong X, Melamed J, Chen H, Bieberich CJ, Borowsky AD, Kung HJ, Wei G, Ostrowski MC, Brodie A, Qiu Y.

Cancer Res. 2006 Aug 15;66(16):8058-64.

40.

NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.

Li X, Guan B, Maghami S, Bieberich CJ.

Mol Cell Biol. 2006 Apr;26(8):3008-17.

41.

Distinct regulatory elements mediate the dynamic expression pattern of Nkx3.1.

Chen H, Mutton LN, Prins GS, Bieberich CJ.

Dev Dyn. 2005 Dec;234(4):961-73.

42.

Structural and functional analysis of domains mediating interaction between NKX-3.1 and PDEF.

Chen H, Bieberich CJ.

J Cell Biochem. 2005 Jan 1;94(1):168-77.

PMID:
15523673
43.

Ventral prostate predominant l, a novel mouse gene expressed exclusively in the prostate.

Wubah JA, Fischer CM, Rolfzen LN, Khalili M, Kang J, Green JE, Bieberich CJ.

Prostate. 2002 Apr 1;51(1):21-9.

PMID:
11920954
44.

NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter.

Chen H, Nandi AK, Li X, Bieberich CJ.

Cancer Res. 2002 Jan 15;62(2):338-40.

45.

Influence of neonatal estrogens on rat prostate development.

Prins GS, Birch L, Habermann H, Chang WY, Tebeau C, Putz O, Bieberich C.

Reprod Fertil Dev. 2001;13(4):241-52.

PMID:
11800163
46.

Differential effects on T cell and NK cell development by tissue-specific expression of H-2D(d) transgene.

Johansson MH, Bieberich C, Kâse-Sjöström A, Yoshioka T, Höglund E, Christy BA, Scangos G, Kärre K, Jay G, Höglund P.

Eur J Immunol. 2000 Feb;30(2):525-33.

47.

Androgen-independent expression of hoxb-13 in the mouse prostate.

Sreenath T, Orosz A, Fujita K, Bieberich CJ.

Prostate. 1999 Nov 1;41(3):203-7.

PMID:
10517879
48.

Hematopoietic progenitor cell abnormalities in Hoxc-8 null mutant mice.

Shimamoto T, Tang Y, Naot Y, Nardi M, Brulet P, Bieberich CJ, Takeshita K.

J Exp Zool. 1999 Feb 1;283(2):186-93.

PMID:
9919689
49.

Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene.

Johansson MH, Bieberich C, Jay G, Kärre K, Höglund P.

J Exp Med. 1997 Aug 4;186(3):353-64.

50.

Prostate-specific and androgen-dependent expression of a novel homeobox gene.

Bieberich CJ, Fujita K, He WW, Jay G.

J Biol Chem. 1996 Dec 13;271(50):31779-82.

Supplemental Content

Loading ...
Support Center